Finesse Solutions launches new bioreactors for R&D, process development scale-up

Designed to optimize yield in both R&D and cGMP applications, the autoclavable bioreactors are compatible with Finesse G3Lab controllers, and SmartAdapters and can be used with third party controllers.

Finesse Solutions R&D vice president and co-founder Dr. Mark Selker said the design improvements will optimize the SmartGlass platform for cell culture and fermentation processes.

"For examples, our cold finger has increased surface area to enable faster thermal control and increase cooling capacity so that a single-wall vessel can be used for fermentation," Selker added.

"The vessels have been designed using all of the machinery available for computational fluid mechanics simulations."

Manufactured maintaining the standards for surface finish and safety of operation, the vessels are expected to ensure complete process sterility and minimize lost batches.